"International Proteomics Day in KOBE" Held in Kobe on March 3rd; Winners of "2026 Japan Proteomics Research Grant Award" Announced

FonesLife Corporation hosted "International Proteomics Day in KOBE" on March 3, 2026, bringing together researchers to share the latest in proteomics. The event also announced the recipients of the "2026 Japan Proteomics Research Grant Award," a program jointly organized with SomaLogic Inc. to support innovative research utilizing proteome analysis services.

📋 Article Processing Timeline

  • 📰 Published: April 2, 2026 at 20:00
  • 🔍 Collected: April 2, 2026 at 14:00
  • 🤖 AI Analyzed: April 17, 2026 at 20:33 (366h 33m after Collected)

FonesLife Corporation (Headquarters: Chuo-ku, Tokyo; Representative Director CEO: Naohito Egawa; hereinafter "the Company") held the "International Proteomics Day in KOBE," an event for researchers in the field of proteomics, on March 3, 2026, at the Kobe International Conference Center. This event invited leading researchers from Japan and abroad to share insights on the latest technologies, application examples, and future possibilities in proteomics research. It also provided an opportunity for researchers to deepen their exchanges.

Additionally, the winners of the "2026 Japan Proteomics Research Grant Award," a public call research grant program jointly organized by SomaLogic Inc. (USA) and the Company, were announced at the venue.

Furthermore, a video of the day's proceedings has been released on the Company's official YouTube channel.
The video can be viewed below:
[Key to Disease Research & New Drug Development] Sneak Peek into a Research Presentation Event Using Comprehensive Measurement of Approximately 11,000 Types of Proteomes - YouTube


■ Event Overview

"International Proteomics Day in KOBE" was held with the aim of sharing information on proteomics research and fostering deeper exchanges among researchers.
On the day, in addition to an online lecture by Dr. Sara Ahadi of OmicsEra, lectures were given by researchers active in various fields, presenting on a wide range of themes including specific use cases of proteomics and the latest research trends.
Active Q&A sessions and opinion exchanges also took place at the venue, and the event concluded successfully.

<Event Details>
Name: International Proteomics Day in KOBE
Date and Time: March 3, 2026 (Tuesday) 13:00~
Venue: Kobe International Conference Center
Content: Lectures on proteomics, information exchange, announcement of research grant program awardees, etc.


■ Winners of the "2026 Japan Proteomics Research Grant Award" Announced

During the event, the winners of the "2026 Japan Proteomics Research Grant Award," a public call research grant program jointly organized by SomaLogic Inc. (USA) and the Company, were announced.

This program aims to support research initiatives that lead to the advancement of research and new discoveries by soliciting research proposals that utilize the Company's proteome analysis services.

The selection process first confirmed that the applications met the eligibility requirements, followed by a comprehensive review of the research's novelty, potential for new discoveries related to health and disease, and future development prospects. As a result, five awardees were selected.

<List of Awardees>

KREX™ Assay

Dr. Hideaki Morita (National Center for Child Health and Development)

Dr. Shintaro Iwama (Nagoya University Hospital)

SomaScan™ 11K Assay

Dr. Yuki Yoshimatsu (Tochigi Cancer Center)

Dr. Yoshinobu Konishi (Kyoto University Hospital)

FonesLife Special Award

Dr. Sumimi Tokuoka (The University of Tokyo Graduate School of Medicine)

We sincerely congratulate all the awardees.

■ Video of the Day's Proceedings Released

A video of the day's proceedings was released on the Company's official YouTube channel on April 2, 2026. This video allows viewers to experience the content and atmosphere of the event through lectures and scenes from the venue. We hope this will be an opportunity for those who could not attend to widely learn about proteomics research and the significance of this event.


Video URL: [Key to Disease Research & New Drug Development] Sneak Peek into a Research Presentation Event Using Comprehensive Measurement of Approximately 11,000 Types of Proteomes

■ Future Outlook

The Company will continue to support the efforts of researchers and contribute to the advancement of proteomics research.

(Related Information)

Event Details
International Proteomics Day in KOBE

Related Press Release
FonesLife Launches First Public Call Research Grant Program "2026 Japan Proteomics Research Grant Award" - FonesLife Corporation

■About FonesLife
FonesLife is a wholly-owned subsidiary of NEC Solution Innovators, providing solutions in the healthcare field through digital technology. By utilizing SomaLogic Inc.'s (USA) blood protein measurement technology and the NEC Group's big data analysis and advanced ICT, we aim to realize a future where "no one gets sick" and "everyone can live life to the fullest" by proposing lifestyle improvements tailored to each individual based on predictions of future disease risks such as dementia.
For details on the disease risk prediction test "Fones Virtuous": https://foneslife.com/

FonesLife also offers the "SomaScan Assay," a proteome analysis service that measures up to approximately 11,000 types of proteins at once to efficiently explore biomarkers, and the "KREX Assay," which can measure approximately 1,800 antibodies simultaneously.

SomaScan Assay: https://discovery.foneslife.com/somascan/ 
KREX Assay: https://discovery.foneslife.com/krex/

Company Name

FonesLife Corporation

Location

3-8-3 Nihonbashi Honcho, Chuo-ku, Tokyo

Representative

Representative Director CEO Naohito Egawa

Capital

325 million yen (100% NEC Solution Innovators)

Business Description

Blood protein measurement
Services related to health status measurement and improvement
Provision of related information services, etc.

URL

https://foneslife.com/company

FonesLife promotes "Health Management" as a "Health Management Company," strategically practicing the management of employee health from a business perspective. Based on the concept of "extending healthy life expectancy and extending the retirement age accordingly," the retirement age is set at an age equivalent to the average healthy life expectancy of Japanese people (currently 75 years old as of 2026). We will continue to review and extend the retirement age in line with the extension of healthy life expectancy. In the era of 100-year lifespans, FonesLife advocates for "realizing a society where everyone can live life to the fullest" and supports employee health by providing flexible work styles such as remote work, flextime, workation, and side jobs (under certain conditions), enabling each employee to work in their own way.


※Company names and product names mentioned are trademarks or registered trademarks of their respective companies.

<Inquiries regarding this matter from customers>

FonesLife

URL: https://foneslife.com/contact/

<Inquiries regarding this matter from media representatives>

FonesLife Public Relations

E-mail: fones-mk@nes.jp.nec.com